Global Sepsis Market, By Type (Diagnosis, Therapeutics), Product (Reagents, Assay, Instruments, Software), Technology (Microbiology, PCR, Sequencing, Biomarkers), Test Type (Lab, POC), Pathogen (Bacterial, Viral, Fungal), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), End User (Hospitals, Pathology and Reference Laboratories), Application (Sepsis, Severe Sepsis, Septic Shock) – Industry Trends and Forecast to 2029
Market Analysis and Size
Surging cases of various infectious diseases which results in growing sepsis prevalence is estimated to drive the market’s growth across the globe. The sepsis market is largely influenced by surging focus of key players towards technological advances in the field of molecular diagnostics and indulging towards collaboration and partnerships with other organizations. Owing to the presence of various growth determinants the market is being propelled forward and is projected to show substantial growth over the forecasted period.
- Global sepsis market was valued at USD 3.3 billion in 2021 and is expected to reach USD 6.8 billion by 2029, registering a CAGR of 8.5% during the forecast period of 2022-2029. The “bacterial” accounts for the largest pathogen segment in the sepsis market within the forecasted period owing to the rise in the bacterial sepsis cases and the rising prevalence of HAIs. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Sepsis is a dangerous consequence that results from a weakened immune system, making patients vulnerable to bacterial, viral, fungal, parasitic, and other illnesses. It's one of the leading causes of mortality in hospitals. When the host's immune system responds to an infection, chemicals are produced by the immune system to treat the infection, resulting in sepsis. As it enters the bloodstream, it induces inflammation throughout the body. It further leads to the blood vessel leakage, blood clots, and poor blood flow, depriving the body's critical organs of oxygen and nutrition.
The sepsis is also considered as a three-staged illness that generally starts with sepsis, then progresses to severe sepsis, and lastly to septic shock, which is a medical emergency. People with a weakened immune system, youngsters, the elderly, and those suffering from chronic illnesses including diabetes, AIDS, cancer and others are at a higher risk of acquiring sepsis.
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019 - 2014)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Diagnosis, Therapeutics), Product (Reagents, Assay, Instruments, Software), Technology (Microbiology, PCR, Sequencing, Biomarkers), Test Type (Lab, POC), Pathogen (Bacterial, Viral, Fungal), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), End User (Hospitals, Pathology and Reference Laboratories), Application (Sepsis, Severe Sepsis, Septic Shock)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa
|
|
Market Players Covered
|
bioMérieux (France), BD (US), Danaher (US), Biosystems Inc., (US), Luminex Corporation (US), F. Hoffmann-La Roche Ltd., (Switzerland), Thermo Fisher Scientific Inc., (US), Bruker (US), Abbott (US), Immunexpress Inc. (U.S), Axis-Shield Diagnostics Ltd. UK), Quidel Corporation (US), Siemens (Germany), EKF Diagnostics (UK), Seegene Inc., (South Korea), Boditech Med Inc., (South Korea), and Alifax S.r.l. Italy (Italy),
|
Sepsis Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
Drivers
-
Growing Burden Of Infectious Diseases
The growing burden of infectious diseases which leads to the rising number of sepsis incidences, is the most significant factor driving the growth for this market. Growing cases of the hospital-acquired infections (HAIs) such as urinary tract infections, pneumonia and sepsis are also expected to accelerate the overall growth of the market.
Growing Investments and Advancements
An increase in funding for sepsis-related research activities combined with the rising investments in extensive research and development activities that include new blood culture approaches for identifying and treating chronic infections are also projected to cushion the growth of the market. Moreover, the technological advances in the field of molecular diagnostics, coupled with surging requirement for quick and accurate results are estimated to generate lucrative opportunities for the market. Various technological advancements have led to the emergence of novel immunological and molecular biomarkers that enable the early detection of sepsis, which will further expand the sepsis market's growth rate in the future.
Furthermore, the expanding healthcare sector along with the increasing penetration of advanced data analytics tools are also expected to fuel market growth. Moreover, the rising awareness among the patients and doctors regarding the chronic diseases and hospital acquired infections also cushions the market’s growth within the forecasted period.
Restraints/Challenges
-
High Costs of Diagnosis
On the other hand, cost of molecular diagnostic tests is very high, which is expected to obstruct market growth.
-
Dearth of Professionals
Also, the sepsis needs to be diagnosed and treated early with help of skilled healthcare professionals. The shortage of skilled professionals or lack of trained paramedics are projected to challenge the sepsis market in the forecast period of 2022-2029.
This sepsis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the sepsis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Post Covid-19 Impact on Sepsis Market
The sepsis market was largely industry impacted by the outbreak of COVID-19. The sepsis symptoms such as multiorgan damage emerged in approximately 2- 5% of COVID patients, that too after 8-10 days of admission. To deal with the dilemma, the Biomedical Advanced Research and Development Authority collaborated with Beckman Coulter to build a digital algorithm to detect sepsis in COVID-19 patients. The outbreak of coronavirus and the emergence of sepsis cases among covid-19 patients boosted the demand for quick diagnosis, resulting in a faster adoption of devices, reagents, and test kits for sepsis detection. Moreover, the geriatric population are vulnerable to complications such as acute respiratory distress syndrome (ARDS) that is caused by pneumonia and raises the risk of sepsis.
Recent Developments
- In June 2021, BioMérieux, a global pioneer in in vitro diagnostics, and Special Diagnostics, a business that brings new in vitro diagnostic methods to clinical microbiology, have inked a distribution agreement for a specific reveal fast AST system in Europe. The REVEAL Rapid AST system, developed by Specific Diagnostics and based on its patented metabolomic signature technology, provides actionable results for bloodstream infections (in an average of 5 hours* directly from positive blood culture), allowing either timely de-escalation to a more focused, more appropriate, and lower-cost therapy, or life-saving rapid escalation to a more effective drug when a multidrug-resistant (MDR) infection is present.
Global Sepsis Market Scope
The sepsis market is segmented on the basis of type, product, technology, test type, pathogen, distribution channel, end user and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Diagnosis
- Therapeutics
On the basis of type, the sepsis market is segmented into diagnosis and therapeutics.
Product
- Reagents
- Assay
- Instruments
- Software
On the basis of product, the sepsis market is segmented into reagents, assay, instruments and software.
Technology
- Microbiology
- PCR
- Sequencing
- Biomarkers
On the basis of technology, the sepsis market is segmented into microbiology, PCR, sequencing and biomarkers.
Test Type
- Lab
- POC
On the basis of test type, the sepsis market is segmented into lab and POC.
Pathogen
- Bacterial
- Viral
- Fungal
On the basis of pathogen, the sepsis market is segmented into bacterial, viral and fungal. The bacterial segment accounts for the largest share of market during the forecast period due to the rise in the bacterial sepsis cases and the rising prevalence of HAIs.
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
On the basis of distribution channel, the sepsis market is segmented into hospital pharmacies, retail pharmacies and online pharmacies.
End User
- Hospitals
- Pathology
- Reference Laboratories
On the basis of end user, the sepsis market is bifurcated into hospitals, pathology and reference laboratories.
Application
- Sepsis
- Severe Sepsis
- Septic Shock
On the basis of application, the sepsis market is bifurcated into sepsis, severe sepsis and septic shock.
Sepsis Market Regional Analysis/Insights
The sepsis market is analyzed and market size insights and trends are provided by country, type, product, technology, test type, pathogen, distribution channel, end user and application as referenced above.
The countries covered in the sepsis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the sepsis market because of the increased per capita healthcare expenditure, high demand for better healthcare facilities, growing adoption of new and advanced diagnostic techniques and increasing incidences of chronic diseases such as cancer, diabetes leading to sepsis within the region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the high geriatric population, increasing prevalence of cancer and diabetes in countries such of India, China, and Australia along with the developing healthcare infrastructure within the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The sepsis market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for sepsis market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the sepsis market. The data is available for historic period 2010-2020.
Competitive Landscape and Sepsis Market Share Analysis
The sepsis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to sepsis market.
Some of the major players operating in the sepsis market are bioMérieux (France), BD (US), Danaher (US), Biosystems Inc., (US), Luminex Corporation (US), F. Hoffmann-La Roche Ltd., (Switzerland), Thermo Fisher Scientific Inc., (US), Bruker (US), Abbott (US), Immunexpress Inc. (U.S), Axis-Shield Diagnostics Ltd. UK), Quidel Corporation (US), Siemens (Germany), EKF Diagnostics (UK), Seegene Inc., (South Korea), Boditech Med Inc., (South Korea) and Alifax S.r.l. Italy (Italy), among others.
SKU-